Hansa Biopharma AB announced a partnership with Cradle to utilize its AI-driven protein design platform for developing new immunomodulatory therapies targeting autoimmune diseases. This collaboration aims to enhance Hansa's discovery pipeline and accelerate therapeutic development.
Company Information
Company
Hansa Biopharma
Location
Lund, Skåne County, Sweden
About
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions.
Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.